Industry

Industry Sci&Tech

Basic Jargon in Technology Licensing

When licensing technology from a university or partner company, several key terms (jargon))are crucial to understand. As a scientists or engineers you should familiarize yourself with these terms which typically appear in a technology transfer agreement (TTA). Below are the core...

Biotech Industry Pharmaceutical

Biotech Business Model：Hub-and-Spoke

The biotechnology business model is characterized by high risk, high reward, and a long development timeline. There is an increasing trend of “hub and spoke” business models, where companies have multiple subsidiary companies, each focused on...

Industry Pharmaceutical

What Sells Innovative Drugs

The landscape of innovative drug development is primarily shaped by First-in-Class (FIC) and Best-in-Class (BIC) molecules. FIC molecules, through their pioneering nature, define new therapeutic pathways, providing a crucial first-mover advantage. BIC molecules, on the other...

Biotech GLP Industry Pharmaceutical Regulation

Understanding about the FDA’s Embrace of New Approach Methodologies

In a landmark decision signaling a paradigm shift in pharmaceutical safety assessment, the U.S. Food and Drug Administration (FDA) announced on April 10, 2025, a plan to phase out the requirement for animal testing in the...

Industry Pharmaceutical

The “NewCo” Revolution: Fueling Chinese Biotech’s Global Ascent

China’s biotech sector is transforming through the “NewCo” model, a strategic spin-off approach designed to accelerate innovation and secure international investment. This model involves creating independent companies (“NewCos”) that house promising drug development assets, effectively decoupling...

Industry Pharmaceutical Sci&Tech

Combination Drugs-Synergistic Therapy

A combination drug, or a fixed-dose combination (FDC), is a medication that includes two or more active ingredients combined into a single dosage form. Synergy occurs when drugs utilized in combination lead to a combined total effect...

Industry Pharmaceutical

An article to learn the Chinese new drug industry

We all heard the Chinese biotechs are booming. I am always wondering if there are statiscal data to learn about the innovative drug development in China. Recently, a research article titled “Chinese innovative drug R&D trends in...

Industry Pharmaceutical

The status quo of antitivrus drugs

Developing effective antiviral drugs is a complex task due to the rapid evolution of viruses. Viruses can develop resistance to antiviral drugs, making it necessary to continually develop new treatments. Additionally, viruses often rely on host...

Industry Pharmaceutical PopSci

Are drugs too expensive?

The question of whether prescription drugs are too expensive is a complex one. While there’s no simple answer, it’s clear that the cost of many medications has risen dramatically in recent years. This has led...

Industry Pharmaceutical

21 FDA approved small molecular drugs in 2024

As Christmas is approaching, 2024 marked a significant year for drug development, with the FDA approving numerous novel therapies across various therapeutic areas. Rare diseases experienced a transformative year in 2024, with drugs accounting for 23.8% of...